Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.72 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.66 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.66 |
| ▸ | GLP1R | P43220 | 5/20 | 0.62 |
| ▸ | NPY2R | P49146 | 7/20 | 0.62 |
| ▸ | NPY4R | P50391 | 7/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.62 |
| ▸ | NPY1R | P25929 | 5/20 | 0.62 |
| ▸ | GCGR | P47871 | 1/20 | 0.61 |
| ▸ | GIPR | P48546 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6238339 | 1.00 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL29356926 | 1.00 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL29636950 | 0.99 | CALCR (0.72) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL11662997 | 0.98 | CALCR (0.71) | CALCRCRHR1CRHR2GLP1RNPY2R | |
| SCHEMBL11663083 | 0.97 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11660011 | 0.96 | CALCR (0.72) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11598563 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11662240 | 0.96 | CALCR (0.70) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11656995 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL11667572 | 0.96 | CALCR (0.71) | CALCRCRHR1CRHR2NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CALCR 118/4885CRHR1 195/4885CRHR2 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.